Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Ian Goodfellow
Affiliation
University of Cambridge
ORCID
Career Start Year
1996
Papers
181
H Index
50
Expertise
CM4AI Collaborator
Kirsten Obernier (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36928598
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis.
Commun Biol
2023
36943868
Leaked genomic and mitochondrial DNA contribute to the host response to noroviruses in a STING-dependent manner.
Cell Rep
2023
37400776
Hepatitis C Virus in people with experience of injection drug use following their displacement to Southern Ukraine before 2020.
BMC Infect Dis
2023
36996074
Human influenza A virus H1N1 in marine mammals in California, 2019.
PLoS One
2023
36781923
Author Correction: Tracking SARS-COV-2 variants using Nanopore sequencing in Ukraine in 2021.
Sci Rep
2023
36896134
Phylodynamics and migration data help describe HIV transmission dynamics in internally displaced people who inject drugs in Ukraine.
PNAS Nexus
2023
34608459
The role of viral genomics in understanding COVID-19 outbreaks in long-term care facilities.
Lancet Microbe
2022
35441162
Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxis.
bioRxiv
2022
35641961
SARS-COV-2 vaccine responses in renal patient populations.
BMC Nephrol
2022
36533153
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK.
Virus Evol
2022
36131001
Tracking SARS-COV-2 variants using Nanopore sequencing in Ukraine in 2021.
Sci Rep
2022
35864233
Author Correction: SARS-CoV-2 evolution during treatment of chronic infection.
Nature
2022
36058413
A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospital.
J Infect
2022
35893676
TRIM7 Restricts Coxsackievirus and Norovirus Infection by Detecting the C-Terminal Glutamine Generated by 3C Protease Processing.
Viruses
2022
36343994
Demographic, behavioural and occupational risk factors associated with SARS-CoV-2 infection in UK healthcare workers: a retrospective observational study.
BMJ Open
2022
35190592
Heat inactivation of clinical COVID-19 samples on an industrial scale for low risk and efficient high-throughput qRT-PCR diagnostic testing.
Sci Rep
2022
34942634
Evolution of enhanced innate immune evasion by SARS-CoV-2.
Nature
2022
35332335
Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2.
Nature
2022
35210470
Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facility.
Sci Rep
2022
35143756
B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination.
Cell Rep
2022
35136068
Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission.
Nat Commun
2022
35106603
A2B-COVID: A Tool for Rapidly Evaluating Potential SARS-CoV-2 Transmission Events.
Mol Biol Evol
2022
34787460
Akt Plays Differential Roles during the Life Cycles of Acute and Persistent Murine Norovirus Strains in Macrophages.
J Virol
2022
34051148
Longitudinal analysis reveals that delayed bystander CD8+ TÂ cell activation and early immune pathology distinguish severe COVID-19 from mild disease.
Immunity
2021
33853966
The Cryo-EM Structure of Vesivirus 2117 Highlights Functional Variations in Entry Pathways for Viruses in Different Clades of the <i>Vesivirus</i> Genus.
J Virol
2021
33830018
Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection.
Elife
2021
33493182
Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion.
PLoS Pathog
2021
33650490
Genomic epidemiology of COVID-19 in care homes in the east of England.
Elife
2021
34873595
Tracking SARS-COV-2 Variants Using Nanopore Sequencing in Ukraine in Summer 2021.
Res Sq
2021
34708158
Design, development, and validation of a strand-specific RT-qPCR assay for GI and GII human Noroviruses.
Wellcome Open Res
2021
34698626
Interferon responses to norovirus infections: current and future perspectives.
J Gen Virol
2021
34491891
Murine norovirus virulence factor 1 (VF1) protein contributes to viral fitness during persistent infection.
J Gen Virol
2021
34425938
Superspreaders drive the largest outbreaks of hospital onset COVID-19 infections.
Elife
2021
34387545
Patterns of within-host genetic diversity in SARS-CoV-2.
Elife
2021
34019938
A luciferase-based approach for measuring HBGA blockade antibody titers against human norovirus.
J Virol Methods
2021
34127972
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant.
bioRxiv
2021
34346771
Murine Norovirus Infection Results in Anti-inflammatory Response Downstream of Amino Acid Depletion in Macrophages.
J Virol
2021
32558644
Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19.
Elife
2020
31905230
Norovirus infection results in eIF2α independent host translation shut-off and remodels the G3BP1 interactome evading stress granule formation.
PLoS Pathog
2020
31953031
Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease:  plasma concentrations exceed target levels, with drug accumulation in the most severe patients.
EBioMedicine
2020
33398302
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation.
medRxiv
2020
33318491
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report.
Nat Commun
2020
33259809
The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2.
Mol Cell
2020
32679081
Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study.
Lancet Infect Dis
2020
32908977
Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore.
bioRxiv
2020
32392129
Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission.
Elife
2020
32184238
Norovirus Replication in Human Intestinal Epithelial Cells Is Restricted by the Interferon-Induced JAK/STAT Signaling Pathway and RNA Polymerase II-Mediated Transcriptional Responses.
mBio
2020
32242791
Replicative fitness recuperation of a recombinant murine norovirus - <i>in vitro</i> reciprocity of genetic shift and drift.
J Gen Virol
2020
30478287
An upstream protein-coding region in enteroviruses modulates virus infection in gut epithelial cells.
Nat Microbiol
2019
31575769
Epigenetic Suppression of Interferon Lambda Receptor Expression Leads to Enhanced Human Norovirus Replication In Vitro.
mBio
2019
1 - 50 of 181
Column Actions
Search
Recommended Authors
Mir M Khalid
Gladstone Institutes
Career Start Year
2016
Number of shared co-authors
20
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year
2015
Number of shared co-authors
24
Andreas S Puschnik
Stanford University School of Medicine
Career Start Year
2013
Number of shared co-authors
4
Craig B Wilen
Yale School of Medicine
Career Start Year
2010
Number of shared co-authors
6
James Zengel
Stanford University School of Medicine
Career Start Year
2010
Number of shared co-authors
4
Xin Yin
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2010
Number of shared co-authors
4
Siyuan Ding
Washington University School of Medicine
Career Start Year
2009
Number of shared co-authors
4
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year
2008
Number of shared co-authors
4
Mohsan Saeed
Boston University Chobanian and Avedisian School of Medicine
Career Start Year
2007
Number of shared co-authors
2
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year
2005
Number of shared co-authors
2
Rachel L Graham
University of North Carolina
Career Start Year
2004
Number of shared co-authors
2
Nolwenn Jouvenet
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year
2003
Number of shared co-authors
20
Yaw Shin Ooi
Duke-NUS Medical School
Career Start Year
2003
Number of shared co-authors
2
Birgit Bradel-Tretheway
Washington State University
Career Start Year
2000
Number of shared co-authors
2
Gaya K Amarasinghe
Washington University School of Medicine at St. Louis
Career Start Year
2000
Number of shared co-authors
4
Sonia Zu??iga
Campus Universidad Autonoma de Madrid
Career Start Year
1999
Number of shared co-authors
11
Amy C Sims
The University of North Carolina at Chapel Hill
Career Start Year
1998
Number of shared co-authors
2
Pei-Yong Shi
University of Texas Medical Branch
Career Start Year
1996
Number of shared co-authors
4
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Career Start Year
1996
Number of shared co-authors
24
Philippe Le Mercier
carnegie mellon university
Career Start Year
1996
Number of shared co-authors
2
Isabel Sola
Campus Universidad Autonoma de Madrid
Career Start Year
1995
Number of shared co-authors
13
John Ziebuhr
Institute of Medical Virology Justus Liebig University
Career Start Year
1995
Number of shared co-authors
9
James D Chappell
Vanderbilt University Medical Center
Career Start Year
1995
Number of shared co-authors
3
Ignacio Mena
Icahn School of Medicine at Mount Sinai
Career Start Year
1994
Number of shared co-authors
25
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year
1993
Number of shared co-authors
3
Andrea V Gamarnik
Fundacion Instituto Leloir-CONICET
Career Start Year
1991
Number of shared co-authors
5
Martin Schwemmle
Institute of Virology, Medical Center - University of Freiburg
Career Start Year
1989
Number of shared co-authors
7
Steven G Widen
University of Texas Medical Branch
Career Start Year
1983
Number of shared co-authors
3
Mark R Denison
Vanderbilt University Medical Center
Career Start Year
1982
Number of shared co-authors
5
Luis Enjuanes
Campus Universidad Autonoma de Madrid
Career Start Year
1971
Number of shared co-authors
15
row(s) 1 - 30 of 30
Collaborators
Myra Hosmillo
University of Cambridge
Co-authored papers
40
Lucy Thorne
University College London
Co-authored papers
24
Aminu S Jahun
University of Cambridge, Addenbrooke's Hospital Level 5
Co-authored papers
16
John R Bradley
Cambridge University Hospitals NHS Foundation
Co-authored papers
9
Tetyana I Vasylyeva
University of California
Co-authored papers
5
Nicholas J Loman
University of Birmingham
Co-authored papers
5
Joel O Wertheim
University of California
Co-authored papers
5
Stephen Matthews
Imperial College London
Co-authored papers
4
Marion Koopmans
Erasmus Medical Center
Co-authored papers
4
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers
4
Andrew Rambaut
Institute of Ecology and Evolution, University of Edinburgh
Co-authored papers
4
Mahdad Noursadeghi
University College London
Co-authored papers
3
Lorena Zuliani-Alvarez
J. David Gladstone Institutes
Co-authored papers
3
Joseph B Hiatt
Fred Hutchinson Cancer Center
Co-authored papers
3
Andrew E Firth
University of Cambridge
Co-authored papers
3
Adrian Pelin
University of Ottawa
Co-authored papers
3
Margaret Soucheray
J. David Gladstone Institutes
Co-authored papers
3
Laura Bergamaschi
Co-authored papers
3
Greg J Towers
University College London
Co-authored papers
3
Matthew V X Whelan
University College London
Co-authored papers
3
Kliment A Verba
University of California, University of California San Francisco
Co-authored papers
3
Kirsten Obernier (CM4AI)
University of California San Francisco
Co-authored papers
3
Gregory J Hannon
Co-authored papers
3
Jyoti Batra
J. David Gladstone Institutes
Co-authored papers
3
Alicia L Richards
University of Wisconsin-Madison
Co-authored papers
3
Kevan M Shokat
University of California San Francisco
Co-authored papers
3
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers
3
Hannes Braberg
University of California San Francisco
Co-authored papers
3
Danish Memon
European Bioinformatics Institute
Co-authored papers
3
Jane Turner
University College London
Co-authored papers
3
1 - 30